Charles B. Nemeroff, MD, PhD

Department of Psychiatry & Behavioral Sciences, University of Texas at Austin, Austin, Texas

  • 36Articles
  • 90.4KReads
  • 1997–2026Active
  • 110Collaborators
  • 55Citations

About

Charles B. Nemeroff, MD, PhD, is affiliated with the Department of Psychiatry & Behavioral Sciences at the University of Texas at Austin. With a publication record spanning from 1997 to 2026, Nemeroff has contributed extensively to research on mood disorders, including major depressive disorder and bipolar disorder, as well as anxiety, posttraumatic stress disorder, schizophrenia, and child and adolescent psychiatry. His work covers clinical studies on pharmacological treatments such as venlafaxine, fluoxetine, paroxetine, and aripiprazole, and explores neurobiological aspects and risk factors associated with these conditions. Nemeroff frequently collaborates with noted colleagues including Alan F. Schatzberg and Madhukar H. Trivedi.

Publications

JCP
Risk Factors for PTSD in a Diverse Cohort of Trauma-Exposed Youth: A 2-Year Longitudinal Study
Original Research

Risk Factors for PTSD in a Diverse Cohort of Trauma-Exposed Youth: A 2-Year Longitudinal Study

June 15, 2026

PTSD at the initial evaluation and at a 1-month follow-up strongly predicted later PTSD in trauma-exposed youth.
, , , et al
JCP
Negative Ethnic-Racial Identity and Internalizing Symptoms in Latiné Youth Exposed to Trauma
Original Research

Negative Ethnic-Racial Identity and Internalizing Symptoms in Latiné Youth Exposed to Trauma

March 17, 2025

In a large group of Latiné youth who had experienced trauma, negative affect about their ethnic racial identity not only was associated with worse internalizing symptoms, but also increased...
, , , et al
JCP
Original Research

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

November 26, 2013

, , , et al
JCP
Commentary

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

October 15, 2013

,
JCP
Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

, , , et al
JCP
Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

, , , et al
JCP
Article

Prevalence and Management of Treatment-Resistant Depression

July 16, 2007

JCP
Article

A Double-Blind, Multicenter, Parallel-Group Study of Paroxetine, Desipramine, or Placebo in Breast Cancer Patients (stages I, II, III, and IV) With Major Depression

February 15, 2006

, , , et al
JCP
Article

Use of Atypical Antipsychotics in Refractory Depression and Anxiety

November 15, 2005

JCP
Article

Introduction.

November 15, 2005

JCP
Original Research

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

October 14, 2005

,
JCP
Article

The Neurobiology of Depression: Inroads to Treatment and New Drug Discovery

August 15, 2005

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe